Product NDC: | 0037-1221 |
Proprietary Name: | Cesamet |
Non Proprietary Name: | Nabilone |
Active Ingredient(s): | 1 mg/1 & nbsp; Nabilone |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0037-1221 |
Labeler Name: | Meda Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA018677 |
Marketing Category: | NDA |
Start Marketing Date: | 20100301 |
Package NDC: | 0037-1221-50 |
Package Description: | 1 BOTTLE in 1 CARTON (0037-1221-50) > 50 CAPSULE in 1 BOTTLE |
NDC Code | 0037-1221-50 |
Proprietary Name | Cesamet |
Package Description | 1 BOTTLE in 1 CARTON (0037-1221-50) > 50 CAPSULE in 1 BOTTLE |
Product NDC | 0037-1221 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Nabilone |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20100301 |
Marketing Category Name | NDA |
Labeler Name | Meda Pharmaceuticals Inc. |
Substance Name | NABILONE |
Strength Number | 1 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cannabinoid [EPC],Cannabinoids [Chemical/Ingredient] |